Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revised consensus standards

This article was originally published in The Gray Sheet

Executive Summary

CDRH will provide a transition period "on a case-by-case basis" during which both old and new versions of a standard will be recognized, according to a 11July 22 guidance. Declarations of conformity can still be accepted during the transition period, which will be included in the "supplemental information sheet" accompanying recognition of a standard. The guidance, superseding a June 2001 document, also clarifies that standards will become effective when their recognition is posted for pre-publication, and not merely on the date of the Federal Register notice...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016977

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel